Lupin's arm gets UK regulator nod for COPD treatment

Global pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a generic version of Spiriva, stated a press release.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ij6wzJb
via IFTTT

0 comments:

Post a Comment